Biocon Biologics gets EU nod for bone disease treatments, including Osteoporosis, giant cell tumour of bone Ruchika Sharma3 July 2025 11:29 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the...
Botox mitigates debilitating dry mouth in prostate cancer patients receiving radiopharmaceutical therapy: Study Dr. Kamal Kant Kohli29 Jun 2025 8:15 PM ISTA dual-protective approach using botulinum toxin (Botox) alongside an anti-nausea patch significantly reduces salivary gland toxicity in patients with...
EMA Committee recommends marketing nod for Bayer advanced prostate cancer drug darolutamide Ruchika Sharma22 Jun 2025 1:00 PM ISTBerlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo Ruchika Sharma19 Jun 2025 10:00 AM ISTBasking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...
UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer Dr. Kamal Kant Kohli17 Jun 2025 8:30 PM ISTMany men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical trial at UC Davis...
Bayer Prostate Cancer Drug Nubeqa gains third regulatory win from USFDA Ruchika Sharma4 Jun 2025 2:59 PM ISTBerlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for its oral androgen receptor inhibitor (ARi) Nubeqa...
Two-week radiotherapy as safe and effective as eight-week course for prostate cancer: phase III trial Dr. Kamal Kant Kohli18 May 2025 9:00 PM ISTProstate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each year . For many patients,...
More men with prostate cancer are avoiding unnecessary surgery, reveals JAMA study Dr. Kamal Kant Kohli14 May 2025 9:00 PM ISTProstate cancer is a leading cause of cancer-related death among men in the United States. Despite this, widespread adoption of prostate cancer...
Diabetes drug as a possible treatment for prostate cancer, reveals research Dr. Kamal Kant Kohli12 May 2025 9:15 PM ISTAn international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as...
Urine test could reveal prostate cancer, reports research Dr. Kamal Kant Kohli2 May 2025 2:15 AM ISTA newly published study involving researchers from Karolinska Institutet indicates that prostate cancer can be diagnosed at an early stage through a...
AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer Ruchika Sharma30 April 2025 12:14 PM ISTTruqap was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics.
